Origin

Origin was established over 50 years ago, based out of our dedicated Pharmaceutical Packaging, Logistics & Innovation Centre. Origin, design, manufacture pharmaceutical packaging and partner with licence holders and CMOs.

Origin joins new facility in world-class science campus Alderley Park to work with UK pharma start-ups

Global pharmaceutical solutions provider, Origin, has announced it’s opening a second UK facility in Alderley Park, the world-class science campus in the North of England. Origin has invested heavily in its New Product Development and Innovation department at its HQ in Melton, East Riding of Yorkshire over the past 24 months and the new facility…

What Does the Future Hold for Clinical Trials

We often here talk about digital technology having the capacity to transform and modernise the life science industry. But on a practical level what does this actually mean and moreover when will this market shift begin to come to fruition? The following insight is Origin’s perspective on the likely changes which will be imparted across…

Artificial Intelligence: What it means to pharma

Following its fast-paced development in recent years, AI is transforming the future of industries. For pharma, in particular, AI is becoming an integral element of drug discoveries, device and packaging design, treatment plans and the pharmaceutical supply chain.  Enabling the industry to operate with increased accuracy and efficiency, AI has the potential to be the…

Act Now. Not Later. Compliant Child Resistant Packaging.

One of our strongest values is protecting children from harmful substances and to ensure that all ‘CR’ packaging is compliant and has gone through the necessary testing. We are on a mission to encourage all brand and license holders on an international scale, to take responsibility in protecting child from their product in the domestic…

The role of pre-filled syringes in delivering the personalised drug revolution

The future of medicine is personalised, based on treating individuals for their risk factors and replacing the traditional universal medicine approach. A leading tool in the delivery of personalised medicine is pre-filled syringes, with over 10.2 million units expected to be sold worldwide by 2026. Pre-filled syringes are revolutionising the way medicine is controlled, delivered…